Christopher Thornton v. HHS - Tdap, Guillain-Barré Syndrome (“GBS”) (2017)

Christopher Thornton filed a petition for compensation on July 11, 2016, alleging that he suffered Guillain-Barré Syndrome (GBS) as a result of a Tdap vaccine administered on May 18, 2015. The respondent denied that the vaccine caused the GBS or any other injury.

However, on May 15, 2017, the parties filed a joint stipulation agreeing that a decision should be entered awarding compensation. The stipulation stated that Christopher Thornton would receive a lump sum of $200,000.00 for all damages.

The Special Master found the stipulation reasonable and adopted it as the decision of the Court, ordering judgment to be entered in accordance with its terms. The public decision does not describe the onset of symptoms, specific medical tests, treatments, or expert witnesses.

Jonathan Pleban represented the petitioner, and Douglas Ross represented the respondent. Special Master Thomas L.

Gowen issued the decision.